Florian Kollert
Overview
Explore the profile of Florian Kollert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
939
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heilmeier U, Feldmann D, Leynes A, Seng M, Jandova I, Keute M, et al.
Front Med (Lausanne)
. 2024 Nov;
11:1446268.
PMID: 39564499
Background: Vasculopathy is a hallmark of systemic sclerosis (SSc) putting patients at an increased risk of cardiovascular disease. Approximately 20-25% of all SSc patients show prolonged elevated C-reactive protein (CRP)...
2.
Shah K, Leandro M, Cragg M, Kollert F, Schuler F, Klein C, et al.
Clin Exp Immunol
. 2024 Apr;
217(1):15-30.
PMID: 38642912
B and T cells collaborate to drive autoimmune disease (AID). Historically, B- and T-cell (B-T cell) co-interaction was targeted through different pathways such as alemtuzumab, abatacept, and dapirolizumab with variable...
3.
Christ L, Kissling S, Finckh A, Fisher B, Adler S, Maurer B, et al.
Arthritis Res Ther
. 2024 Mar;
26(1):68.
PMID: 38481302
Objective: To investigate the clinical phenotype and treatment response in patients with rheumatoid arthritis (RA) with and without concomitant Sjögren's disease (SjD). Methods: In this observational cohort study, patients with...
4.
Christ L, Seitz L, Scholz G, Sarbu A, Amsler J, Butikofer L, et al.
Lancet Rheumatol
. 2024 Jan;
3(9):e619-e626.
PMID: 38287611
Background: Two randomised controlled trials showed a glucocorticoid-sparing effect of tocilizumab in patients with giant cell arteritis. In the GUSTO trial we aimed to evaluate the efficacy and safety of...
5.
Tomizawa T, Cox T, Kollert F, Bowman S, Ito H, Matsuda S, et al.
Clin Exp Rheumatol
. 2023 Dec;
41(12):2484-2492.
PMID: 38149516
Objectives: Rheumatoid arthritis (RA) and Sjögren's syndrome (SS) frequently co-exist but the consequence for RA disease activity of having concomitant SS (RA/SS) is not well established. We conducted a systematic...
6.
Guler S, Sarbu A, Stalder O, Allanore Y, Bernardino V, Distler J, et al.
Thorax
. 2023 Oct;
78(12):1188-1196.
PMID: 37798114
Background: Systemic sclerosis (SSc) is a heterogeneous disease with frequently associated interstitial lung disease (SSc-ILD). We aimed to determine the prognostic potential of phenotyping patients with SSc and SSc-ILD by...
7.
Christ L, Gloor A, Kollert F, Gaber T, Buttgereit F, Reichenbach S, et al.
Front Immunol
. 2023 Jun;
14:1165758.
PMID: 37287970
Objective: Proteome analyses in patients with newly diagnosed, untreated giant cell arteritis (GCA) have not been reported previously, nor are changes of protein expression upon treatment with glucocorticoids (GC) and/or...
8.
Feldmann D, Jandova I, Heilmeier U, Kollert F, Voll R, Finzel S
Front Med (Lausanne)
. 2023 Feb;
9:933809.
PMID: 36743676
Objectives: About 25% of patients with systemic sclerosis (SSc) have elevated C-reactive protein (CRP) levels. Specific causes of CRP elevation are unknown so far. We aimed to investigate whether inflammatory...
9.
Kolev M, Sarbu A, Moller B, Maurer B, Kollert F, Semmo N
J Transl Autoimmun
. 2023 Jan;
6:100189.
PMID: 36718275
Background: The majority of patients with autoimmune hepatitis (AIH) achieve complete remission with established treatment regiments. In patients with intolerance or insufficient response to these drugs, the remaining options are...
10.
Pucino V, Turner J, Nayar S, Kollert F, Rauz S, Richards A, et al.
RMD Open
. 2022 May;
8(1).
PMID: 35589331
Objectives: Given the similarity in symptoms between primary Sjogren's syndrome (SjS) and non-SjS sicca syndrome (sicca), we sought to characterise clinical and proteomic predictors of symptoms in both groups in...